Molnupiravir by Merck

Molnupiravir

Merck Sharp and Dohme (MSD) developed molnupiravir in collaboration with Ridgeback Biotherapeutics. "Molnupiravir is the oral prodrug of beta-D-N4-hydroxycytidine (NHC), a ribonucleoside that has shown antiviral activity against SARS-CoV-2 in vitro and in clinical trials. NHC uptake by viral RNA-dependent…
Adverse Events - news, reports, analysis

Post-jab AE Topics

Adverse Events following COVID-19 injections is a big topic. I am re-organising pages to make content easier to publish and locate. This page will capture the reverse-chronological order format of videos and articles relating to general breaking news and data…
Effectiveness of Vaccine Efficacy

Vaccine Effectiveness

All COVID-19 vaccines are alleged "safe and effective"! "Safe and effective" is a catch-all marketing phrase used for all vaccines. A "rare" side effect, which can include death, still makes it safe in the eyes of the authorities! Putting "safe"…